The Growing Primary Biliary Cholangitis Treatment Market: A Journey Towards $2.72 Billion by 2033 The Primary Biliary Cholangitis treatment market is projected to soar to $2.72 billion by 2033, driven by advancements in therapies and rising patient numbers.

The Growing Primary Biliary Cholangitis Treatment Market: A Journey Towards $2.72 Billion by 2033 #USA #Austin #PBC_Treatment #FXR_Agonists #Immunomodulators